Prediction of coronary artery disease by a systemic atherosclerosis score index derived from whole-body MR angiography by unknown
BioMed Central
Journal of Cardiovascular Magnetic 
Resonance
ssOpen AcceResearch
Prediction of coronary artery disease by a systemic atherosclerosis 
score index derived from whole-body MR angiography
Stephanie Lehrke*, Benjamin Egenlauf, Henning Steen, Dirk Lossnitzer, 
Grigorius Korosoglou, Constanze Merten, Boris T Ivandic, 
Evangelos Giannitsis and Hugo A Katus
Address: Abteilung Innere Medizin III, Medizinische Klinik, Universitätsklinikum Heidelberg, Heidelberg, Germany
Email: Stephanie Lehrke* - stephanie.lehrke@med.uni-heidelberg.de; Benjamin Egenlauf - benjamin.egenlauf@med.uni-heidelberg.de; 
Henning Steen - henning.steen@med.uni-heidelberg.de; Dirk Lossnitzer - dirk.lossnitzer@med.uni-heidelberg.de; 
Grigorius Korosoglou - grigorius.korosoglou@med.uni-heidelberg.de; Constanze Merten - constanze.merten@med.uni-heidelberg.de; 
Boris T Ivandic - boris.ivandic@med.uni-heidelberg.de; Evangelos Giannitsis - evangelos.giannitsis@med.uni-heidelberg.de; 
Hugo A Katus - hugo.katus@med.uni-heidelberg.de
* Corresponding author    
Abstract
Background: Whole-body magnetic resonance angiography (WB-MRA) has shown its potential for the non-
invasive assessment of nearly the entire arterial vasculature within one examination. Since the presence of extra-
cardiac atherosclerosis is associated with an increased risk of coronary events, our goal was to establish the
relationship between WB-MRA findings, including a systemic atherosclerosis score index, and the presence of
significant coronary artery disease (CAD).
Methods: WB-MRA was performed on a 1.5T scanner in 50 patients scheduled to undergo elective cardiac
catheterization for suspected CAD. In each patient, 40 extra-cardiac vessel segments were evaluated and assigned
scores according to their luminal narrowing. The atherosclerosis score index (ASI) was generated as the ratio of
summed scores to analyzable segments.
Results: ASI was higher in patients with significant (> 50% stenosis) CAD (n = 27) vs. patients without CAD (n
= 22; 1.56 vs. 1.28, p = 0.004). ASI correlated with PROCAM (R = 0.57, p < 0.001) and Framingham (R = 0.36, p
= 0.01) risk scores as estimates of the 10-year risk of coronary events. A ROC derived ASI of > 1.54 predicted
significant CAD with a sensitivity of 59%, specificity of 86% and a positive predictive value of 84%. Logistic
regression revealed ASI > 1.54 as the strongest independent predictor for CAD with a 11-fold increase in
likelihood to suffer from significant coronary disease. On the contrary, while 15/27 (55%) of patients with CAD
exhibited at least one extra-cardiac stenosis > 50%, only 3/22 (14%) of those patients without CAD did (p =
0.003). The likelihood for an extra-cardiac stenosis when CAD is present differed between vascular territories
and ranged from 15% for a carotid stenosis to 44% for a stenosis in the lower extremities.
Conclusion: This study provides important new evidence for the close association of extra-cardiac and coronary
atherosclerosis. The novel findings that a WB-MRA derived systemic atherosclerosis score index is not only
associated with established cardiovascular risk scores but is also predictive of significant CAD suggest its potential
prognostic implications and underline the importance to screen for coronary disease in patients with extra-
cardiac manifestations of atherosclerosis.
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Atherosclerotic cardiovascular disease with its conse-
quences of myocardial infarction and stroke is the leading
cause of morbidity and mortality in the Western world
[1]. Although the generalized nature of atherosclerosis has
been recognized for decades [2,3], a systematic screening
in patients presenting with a local manifestation of
atherosclerosis, e.g. coronary artery disease (CAD), is not
routinely performed. This is at least in part attributable to
the lack of an established diagnostic approach as most of
the major imaging techniques are limited by either their
invasiveness (conventional angiography), their inability
to assess large areas of the vascular tree at once (duplex
sonography), their use of ionizing radiation (conven-
tional angiography, computed tomography) and/or the
administration of potentially toxic contrast agents.
In recent years, whole-body magnetic resonance angiogra-
phy (WB-MRA) has evolved as a promising tool for the
comprehensive assessment of nearly the entire arterial tree
within one examination. With the advantages inherent to
magnetic resonance imaging, i.e. lack of radiation expo-
sure and use of well tolerated contrast agents, WB-MRA
possesses the ideal characteristics not only for clinical
assessment of the individual patient but also for epidemi-
ological and interventional studies. In addition, there
have been first reports on the potential of WB-MRA to cre-
ate a single score reflecting the severity of systemic athero-
sclerotic burden [4-7]. In these studies, the respective
"atherosclerosis score" was associated with traditional car-
diovascular risk factors [4] and showed a correlation with
the Framingham risk score [5]. This is in line with obser-
vations about the increased risk of coronary events in
patients with extra-cardiac manifestations of atherosclero-
sis [8,9] and led the authors to postulate that a score of
systemic atherosclerosis might be of value for cardiovas-
cular risk assessment. These findings underline the impor-
tance to systematically establish the relationship between
manifestations of extra-cardiac atherosclerosis as detected
by WB-MRA and the presence and significance of coronary
artery disease; however there is only scarce data on this
question, limited mainly to the application of WB-MRA in
patients with a history of coronary revascularization or
prior myocardial infarction [4,10].
The aim of the present study was to assess the association
between WB-MRA findings and the presence of significant
coronary artery disease in patients undergoing elective
cardiac catheterization. We further sought to evaluate a
newly developed "atherosclerosis score index" as measure
for systemic atherosclerotic burden with regard to its pre-
dictive value for the incidence of CAD and its correlation
with established cardiovascular risk scores and other non-
invasive surrogates for extra-cardiac atherosclerosis.
Methods
Study population
The study population consisted of 50 patients scheduled
to undergo elective cardiac catheterization for suspected
coronary artery disease at the Department of Cardiology,
University Hospital Heidelberg, Germany. Patients were
recruited from the cardiology outpatient clinic during
February and March 2007. A total of 74 consecutive
patients with the indication for elective cardiac catheteri-
zation for suspected CAD were screened. Pre-defined
exclusion criteria for the study were [numbers of patients
excluded based on each criteria]: known extra-cardiac
atherosclerosis [n = 3], age < 18 years [n = 0], inability or
unwillingness to give informed consent [n = 7], pregnancy
[n = 0], renal failure with a glomerular filtration rate < 60
ml/min/1.73 m2 [n = 5] and general contraindications to
MRI such as presence of pacemakers [n = 0], implantable
cardioverter defibrillators [n = 0], intracranial clips [n = 1],
other foreign metallic objects [n = 3] or known severe
claustrophobia [n = 5]. WB-MRA was performed several
days before the date of the scheduled cardiac catheteriza-
tion and ankle-brachial blood pressure index (ABI) was
measured at the time of the MRI scan. PROCAM [11] and
Framingham [12] scores were calculated for each patient
as measures of the likelihood to suffer from a coronary
event within the next 10 years. The study was performed
in accordance to the Declaration of Helsinki. The ethics
committee of the University of Heidelberg approved the
study protocol and all patients gave their written
informed consent.
Whole-body magnetic resonance angiography
Whole-body MRA was performed on a 1.5T clinical scan-
ner (Intera Achieva®, Philips Medical Systems, Best, The
Netherlands) equipped with a table top extender using
MobiTrak® software (Philips Medical Systems). The sys-
tem integrated quadrature body coil was used for signal
transmission and reception. Patients were placed in a
supine position feet-first. A survey scan with a time-of-
flight sequence was performed for subsequent planning.
MRA was acquired with a 3-dimensional T1 RF-spoiled
gradient echo sequence in 4 slightly overlapping coronal
data sets ("stations"). The first station included the adom-
inal aorta and its branches, the second station started at
the external iliac arteries and continued to the popliteal
arteries, the third station contained the arteries of the
lower leg. The fourth station consisted of the thoracic
aorta and its supraaortic branches. Typical scan parame-
ters were: TR 5 ms, TE 1.5 ms, flip angle 40°, FOV 451
mm, acquired voxel sizes 1.66 × 1.74 × 2 mm3 (station 1),
1.41 × 1.71 × 1.8 mm3 (station 2), 1.23 × 1.23 × 0.75 mm3
(station 3) and 1.66 × 1.74 × 2 mm3 (station 4). Recon-
structed voxel size for all stations was 0.88 × 0.88 × 1
mm3. A breath-hold was used for station 1 only [5,6].
After acquisition of unenhanced images, 26 ml of gado-Page 2 of 10
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Pharma, Germany) were power injected (flow rate of 1.2
ml/sec for the first 13 ml, 0.4 ml/sec for the second 13 ml,
followed by 25 ml saline with a flow rate of 0.4 ml/sec).
Scanning of the first three stations was timed using real-
time bolus monitoring (BolusTrak®, Philips Medical Sys-
tems), the image acquisition was started when the distal
aorta and aortic bifurcation were clearly visible with con-
trast. After a wash-out period of 7 minutes, images of the
fourth station were acquired in a similar fashion with the
injection of 14 ml contrast media followed by 25 ml
saline (flow rate for both 2 ml/sec). The scan was started
when the ascending aorta was filled with contrast. For all
stations, unenhanced images were subtracted from
enhanced images. Maximum-intensity-projections were
obtained from subtracted images in standard frontal and
lateral projections. Multiplanar reconstructions were gen-
erated for image interpretation.
Image analysis and calculation of the atherosclerosis score 
index
Interpretation of WB-MRA data was performed on a com-
mercially available work station (ViewForum®, Philips
Medical Systems). For image analysis the arterial tree was
divided into 40 segments ranging from the internal
carotid artery to the arteries of the lower leg (Figure 1A).
Using source images and multiplanar reconstructions all
segments were graded with regard to their diagnostic qual-
ity (0 = non-diagnostic, 1 = poor image quality, diagnosis
suspected, 2 = moderate quality, some blurring/artefacts
but definite diagnosis possible 3 = good quality and 4 =
excellent image quality) and their most severe stenosis
Evaluation of WB-MRAFig re 1
Evaluation of WB-MRA. Panel (A) shows an example for a fused whole body-MRA in a maximum intensity projection (MIP), 
the evaluated vessel segments are listed on the right. The ASI for each patient was calculated according to (B). The ASI in this 
example is 1.16.Page 3 of 10
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sus reading of two experienced observers (S.L. and H.S.)
blinded to the results of coronary angiography and other
clinical data. Reasons for non-diagnostic quality were
noted and included venous overlap, poor signal-to-noise
ratio (SNR), motion artefacts and others (e.g. anatomic
variants, orthopedic implants). All evaluable vessel seg-
ments received a score according to the severity of steno-
sis, ranging from 1 for a normal vessel to 6 for a total
occlusion. The atherosclerosis score index (ASI) for each
patient was calculated by dividing the sum of vessel scores
by the number of analysed segments (Figure 1B).
Coronary angiography
Cardiac catheterization was performed via the femoral or
radial artery and coronary angiograms were obtained
from all patients. Signficant coronary artery disease was
defined as presence of vessel segments with > 50% lumi-
nal narrowing and was classified into 1- 2- and 3 vessel
disease according to number of affected vessels. Coronary
revascularization (percutaneous intervention or bypass
grafting) was recommended at the discretion of the
attending physician and either performed directly or at a
later time point.
Measurement of ankle-brachial blood pressure index (ABI)
The ABI was measured and calculated according to the rec-
ommendations of the American Heart Association [13]. A
blood pressure cuff and a doppler ultrasonic sensor were
used to determine systolic blood pressure in the brachial
arteries and the posterior tibial and dorsalis pedis arteries.
The ABI for each leg equaled the ratio of the higher of the
two systolic pressures (posterior tibial or dorsalis pedis)
and the average of the brachial pressures. In cases where
there was a difference of > 10 mmHg between brachial
artery pressures, the higher value was used. An ABI of < 0.9
was considered a pathological finding.
Statistical analysis
Data were expressed as mean ± SEM or as median with
interquartile range (IQR; 25-75th percentile) if not nor-
mally distributed. Differences between two groups were
compared by Student's t-test or Mann-Whitney-U-Test for
non-parametrical continuous variables. Categorical varia-
bles between groups were compared by chi-square test.
The associations between ASI and Framingham and PRO-
CAM scores were assessed using Pearson's correlation
coefficient. ROC analysis was performed to determine the
optimal ASI cut-off for diagnosis of significant CAD.
Logistic regression analysis was carried out to provide the
optimal model for prediction of the odds for significant
CAD. For all analyses, a p-value of < 0.05 was regarded sta-
tistically significant. All statistical analyses were carried
out using the Statistical Package for Social Science soft-
ware version 16.0 (SPSS Inc., Chicago, USA).
Results
Baseline patients' demographics and results of coronary
angiography are displayed in Table 1. WB-MRA could be
performed in all 50 patients without any adverse reactions
to contrast media or major technical problems. One
patient failed to keep her appointment for the scheduled
cardiac catheterization.
WB-MRA-technical results and detection of stenoses
In 50 patients a total number of 1793/2000 (90%) vessel
segments were evaluable. Excellent and good image qual-
ities were found in 249 (14%) and 1235 (69%) segments
respectively, while 270 (15%) segments showed moderate
and only 39 (2%) poor diagnostic quality. Reasons for the
non-diagnostic quality included motion artefacts (22/
207), poor SNR (151/207), venous overlay (12/207) and
others (22/207). Of the non-evaluable segments 52%
were located in the abdominal area, while 18% were
found in the supraaortic branches and 30% in the lower
extremities.
A total of 27 stenoses > 50% were detected with a distribu-
tion among the different vessel territories as follows: 1.
thoracic aorta/supraaortic branches n = 5 (19%); 2.
abdominal aorta with visceral and pelvical branches n =
10 (37%); 3. lower extremities starting with the common
femoral artery n = 12 (44%). A total of 18 patients (36%)
were found to exhibit at least one luminal narrowing >
50%, among these, 6 patients had two ore more > 50%
stenoses.
The Atherosclerosis Score Index (ASI)
The mean ASI among the study cohort was 1.43 ± 0.05,
ranging from 1 to 2.56. A higher ASI was not associated
Table 1: Baseline patient demographics and results from 
coronary angiography
Age (yrs) 61.7 ± 1.5
Age ≥ 70 yrs - n (%) 14 (28)
Male - n (%) 26 (52)
BMI (kg/m2) 27.6 ± 0.7
Cardiovascular Risk
Diabetes - n (%) 16 (32)
Smoking - n (%) 14 (28)
Hypertension - n (%) 48 (96)
Hyperlipidemia - n (%) 36 (72)
Family history - n (%) 19 (38)
PROCAM Score 48.1 ± 1.9
Framingham Score 7.7 ± 0.53
Coronary angiography
Significant CAD - n (%) 27/49 (55.1)
1 - vessel disease - n (%) 13/49 (26.5)
3 - vessel disease - n (%) 14/49 (28.6)
PCI - n (%) 14/49 (28.6)
CABG - n (%) 3/49 (6.1)
yrs: years; BMI: body mass index; CAD: coronary artery disease;
PCI: percutaneous coronary intervention; CABG: coronary artery 
bypass graftingPage 4 of 10
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vascular risk factors. However, ASI was markedly higher in
patients with an ABI < 0.9 (Table 2). Significant correla-
tions were found between the ASI and PROCAM as well as
Framingham risk scores (Figure 2).
Association between coronary artery disease and WB-
MRA findings
Patients with significant coronary artery disease (n = 27)
exhibited a higher ASI compared to patients without sig-
nificant coronary disease (n = 22; 1.56 vs. 1.28, p =
0.004). Furthermore, ASI was markedly elevated in
patients undergoing coronary revascularization (1.6 vs.
1.34, p = 0.01). ROC analysis revealed an ASI cut-off of
>1.54 as the optimal discriminator for the presence of sig-
nificant CAD with a sensitivity of 59%, a specificity of
86% and a positive predictive value of 84%. Likewise, a
cut-off for severe CAD necessitating coronary revasculari-
zation of >1.6 could be determined with a sensitivity of
59%, a specificity of 90% and a positive predictive value
of 63% (Figure 3). Significant CAD was associated with
the presence of higher grade extra-cardiac stenoses - while
15/27 (55%) of patients with CAD exhibited at least one
extra-cardiac stenosis > 50%, only 3/22 (14%) of those
patients without CAD did (p = 0.003, Figure 4). The inci-
dence of a significant extra-cardiac stenosis when CAD
was present differed between vessel territories. While 4/27
(15%) patients with CAD suffered from carotid artery
stenoses, higher grade stenoses in the abdominal/pelvical
regions were present in 7/27 (26%) patients and a total of
12/27 (44%) patients had concomitant stenoses of the
arteries in the lower extremities.
The presence of a stenosis > 50% was slightly less power-
ful compared to the ASI discriminator in predicting the
presence of CAD with a sensitivity of 56% and a specificity
of 86% (positive predictive value 83%). Figure 5 displays
an example of a patient with a high ASI and 3-vessel cor-
onary disease.
Together with other variables associated with CAD in uni-
variate analysis, the ASI cut-off of 1.54 was used to build
logistic regression models predicting the odds of signifi-
cant CAD. Table 3 displays the best-fit model. Among the
variables entered (age > 70 yrs, male gender, ABI < 0.9,
PROCAM score), the odds ratio was statistically different
from 1 for ASI > 1.54 only. In the specific model, an ASI >
1.54 was associated with a 11-fold increase in likelihood
to suffer from significant CAD. When entered into logistic
regression models as a continuous variable ASI did not
retain its independent predictive value.
Discussion
The present study confirms the close relationship between
extra-cardiac atherosclerosis as assessed by whole-body
magnetic resonance angiography and the presence of cor-
onary artery disease. The major new finding of this study
is the observation that significant coronary artery disease
can be predicted from a WB-MRA derived atherosclerosis
score index reflecting systemic atherosclerosis.
The systemic nature of atherosclerosis has been recog-
nized for decades [2,3]. Despite this fact, the clinician's
attention is usually focused on the local manifestations of
atherosclerosis, e.g. coronary artery disease, peripheral
arterial occlusive disease or cerebrovascular disease,
which are responsible for the patients' symptoms and thus
the reason why medical attention is sought. While the
diagnosis of any form of atherosclerosis will prompt the
initiation of tertiary prevention including medical therapy
and life style modification affecting the whole body, more
specific treatment measures may be necessary for other
locations, e.g. high grade internal carotid artery or renal
artery stenosis. It is therefore desirable to perform a sys-
temic screening in any patient presenting with a manifes-
tation of atherosclerosis.
In recent years whole-body MR angiography has evolved
as a promising non-invasive technique for the assessment
of nearly the entire arterial system in one examination.
The feasibility of this technique on routine clinical 1.5 T
MRI scanners has been widely established [14-17] and in
terms of diagnostic accuracy excellent agreements with
digital subtraction angiography as the gold standard could
be shown [18-20]. As a multi-station bolus-chase tech-
nique, WB-MRA possesses the inherent difficulty of opti-
Table 2: ASI according to age, gender, traditional risk factors and ABI
ASI ASI p-value
male gender 1.47 ± 0.08 female gender 1.39 ± 0.06 ns
diabetes 1.49 ± 0.1 no diabetes 1.4 ± 0.05 ns
age ≥ 70 yrs 1.58 ± 0.11 age < 70 yrs 1.37 ± 0.05 ns
smoker 1.43 ± 0.07 non-smoker 1.43 ± 0.06 ns
hypertension 1.44 ± 0.05 no hypertension 1.17 ± 0.03 ns
hyperlipidemia 1.44 ± 0.06 no hyperlipidemia 1.4 ± 0.09 ns
ABI = 0.9 1.76 ± 0.12 ABI > 0.9 1.36 ± 0.05 0.01
ASI: atherosclerosis score index; yrs: years; ABI: ankle-brachial blood pressure indexPage 5 of 10
(page number not for citation purposes)
Journal of Cardiovascular Magnetic Resonance 2009, 11:36 http://www.jcmr-online.com/content/11/1/36mal timing of image acquisition to keep up with the
contrast bolus. This is especially challenging with regard
to smaller arteries in the calf region where a higher spatial
resolution is desirable but leads to longer acquisition
times which in turn increase the venous contamination
and thus hamper the diagnostic accessibility. One solu-
tion to this problem is the application of a sub-systolic
venous compression which can be achieved by the appli-
cation of a blood pressure cuff to the thigh region. Venous
thigh compression was shown in WB-MRA to improve
SNR and CNR, to ameliorate venous contamination and
to lead to a higher sensivity and specificity for the detec-
Association between ASI and cardiovascular risk scoresFigure 2
Association between ASI and cardiovascular risk scores. ASI showed a good correlation with PROCAM (A) and Fram-
ingham (B) scores, suggesting its possible prognostic value.
Prediction of CAD and coronary revascularization by ROC derived ASI cut-offsFigure 3
Prediction of CAD and coronary revascularization by ROC derived ASI cut-offs. While an ASI > 1.54 proved to be 
the optimal discriminator for presence of significant coronary artery disease (A), the need for coronary revascularization was 
best predicted by a slightly higher ASI cut-off of 1.6 (B). For both, the sensitivities were 59%, the specificity for prediction of 
CAD was 86% (positive predictive value 84%) and the specificity for precition of coronary revascularization was 90% (positive 
predictive value 63%).Page 6 of 10
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oses which had been found by DSA [21,22]. Importantly,
venous compression changes contrast dynamics [23] and
contrast flow rates need to be adapted [24].
Apart from subsystolic venous compression, which
mainly aims at improving image quality in the distal por-
tions of the lower extremities, an established method to
increase signal, decrease scanning times and/or improve
spatial resolution in MRA is the application of parallel
imaging techniques with the use of multi-channel receiver
coils. These have already successfully been applied to MR
whole body angiography [16,19,25]. While this approach
leads to an improvement in image quality, it requires spe-
cial hardware. In this study, we aimed to apply an easy- to
- use protocol by using the system integrated quadrature
body coil and refrained from using venous thigh compres-
sion.
With regard to clinical applications, the potential of WB-
MRA to detect unknown arterial disease was demon-
strated in different patient cohorts such as diabetics [4],
patients with a history of coronary revascularization or
myocardial infarction [10] and a large population of eld-
erly Swedish citizen [6]. The impact of the diagnosis of
Association of higher-grade extra-cardiac stenoses with sig-nificant CADFigure 4
Association of higher-grade extra-cardiac stenoses 
with significant CAD. While 55% of patients with CAD 
had at least one higher-grade (> 50%) extra-cardiac stenosis, 
only 14% of patients without CAD did (* p = 0.003). On the 
contrary, 15/18 (83%) patients who showed a higher-grade 
extra-cardiac stenosis also suffered from significant coronary 
artery disease. (Grey columns: patients without higher-grade 
extra-cardiac stenoses; red columns: patients with higher-
grade extra-cardiac stenoses).
Patient exampleFigure 5
Patient example. WB-MRA of a 63 year old male with ste-
nosis of the left common iliac artery (A, red arrow), occlu-
sion of both superficial femoral arteries (B, blue arrows) with 
collateralization by the profund femoral arteries (blue arrow-
heads) and occlusion of the right posterior tibial artery (C, 
green arrow) with collaterals from the anterior tibial artery 
(C, green arrowhead). The patient did not complain about 
claudicatio at the time of the exam. Based on the results of 
WB-MRA regular angiological follow-ups were initiated. 
About 1 year after the MRA angioplasty of the left iliac artery 
was performed. Coronary angiography revealed 3-vessel dis-
ease and the patient underwent PCI of the left anterior 
descending artery. ASI and PROCAM Score were high.Page 7 of 10
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patients with peripheral arterial occlusive disease was
demonstrated by Goyen et al [26].
In addition to the detection of individual high-grade sten-
otic lesions with consequences for the treatment strategy
of the patient, the systemic nature of atherosclerosis
makes it tempting to establish a marker reflecting the total
atherosclerotic burden to be used for epidemiological and
interventional studies. With this in mind we used the
information from WB-MRA to design an atherosclerosis
score index, which is similar to the one recently published
by two other groups [4,5] in selected patient populations.
The good correlation of the vessel scores with cardiovascu-
lar risk factors such as smoking, systolic blood pressure,
male gender and the Framingham Risk Score [4], the latter
being confirmed in our own findings, makes it tempting
to speculate that this score may be of prognostic signifi-
cance. This idea is supported by earlier reports in which
non-invasive measures of extracoronary atherosclerosis
such as ankle-brachial-index and intima-media thickness
were shown to be associated with an increased risk of car-
diovascular events [8,9], and that on a morphological
level coronary artery disease as detected by computed
tomography is associated with extra-cardiac atherosclero-
sis [10,27,28].
The strong association between coronary and extra-coro-
nary atherosclerosis is confirmed by our own results. The
presence of significant coronary artery disease was associ-
ated with a pronounced systemic atherosclerotic burden
as reflected by a markedly increased atherosclerosis score
index. In our study population of patients undergoing car-
diac catheterization for clinically suspected coronary dis-
ease a fairly large percentage (45%) did not exhibit
significant (i.e. > 50% stenosis) CAD. This led us to the
question whether ASI can help to discriminate between
patients with vs. without significant coronary disease. In
fact, a ROC analysis derived ASI cut-off of > 1.54 had a
sensitivity of 59%, a specificity of 86% and a positive pre-
dictive value for CAD of 84%. When entered into logistic
regression models an ASI > 1.54 remained the strongest
independent predictor for CAD. In addition to the some-
what complex ASI the presence of a single > 50% extra-car-
diac stenosis also showed a relatively good positive
predictive value for significant CAD (83%), was however
not as strong a predictor when entered into logistic regres-
sion models. Interestingly, despite the good specificity,
the use of WB-MRA to screen for CAD to potentially avoid
cardiac catheterization can not be recommended at this
time as peripheral atherosclerosis has a low sensitivity to
detect CAD with only 55% of patients with CAD showing
higher-grade extra-cardiac stenoses. This prevalence is
comparable with the WB-MRA findings reported in
patients with known coronary artery disease by Ladd et al
[10] and in line with earlier reports assessing extra-cardiac
atherosclerosis in patients with CAD by other non-inva-
sive methods [29]. These observations in conjunction
with the finding that the percentage of CAD patients
exhibiting other atherosclerotic manifestations increases
with advanced age [29], support the theory that coronary
artery disease is an early manifestation of atherosclerosis.
The use of WB-MRA to screen for CAD and potentially
avoid cardiac catheterization can therefore not be recom-
mended.
Despite the promising reports about a WB-MRA derived
atherosclerosis score by us and others [4-7], the technique
is limited by the fact that it is a "luminography" and does
not image plaque burden or plaque vulnerability. With
new technical developments leading to higher spatial res-
olution it may be feasible in the future to combine WB-
MRA with plaque imaging in a reasonable amount of
time. Importantly, if a WB-MRA derived atherosclerosis
scoring system is to become an established method, it
needs to be standardized to allow reproducibility. The
three scoring systems, including ours, which have been
developed almost simultaneously, differ in their
approaches. The total atherosclerosis score by Hansen et
al. is based on the evaluation of 26 vessel segments
divided into 5 territories to allow for a weighting of differ-
ent stenosis localizations over others (e.g. a carotid artery
stenosis contributes more to the total score than a tibial
artery stenosis) [5]. Weckbach et al used a system to calcu-
late their atherosclerosis score similar to ours, however
evaluated only 22 vessel segments [4]. Our own ASI is
characterized by grading of a large number of vessel seg-
Table 3: Logistic regression for prediction of significant coronary artery disease
B S.E. p-value OR 95% CI
PROCAM Score (per point) -0.02 0.05 0.69 0.98 0.89-1.08
Age (per year) -0.01 0.04 0.9 1 0.93-1.07
Male gender 1.21 0.7 0.08 3.37 0.85-13.3
ABI < 0.9 0.53 1.12 0.64 1.7 0.19-15.33
ASI > 1.54 2.4 0.92 0.009 10.99 1.8-67.1
ABI: ankle-brachial blood pressure index; ASI: atherosclerosis score indexPage 8 of 10
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directly comparable, the published results complement
each other very well and underline the potential of this
new method.
One limitation of our study is that not all vessel segments
were evaluable. Diagnostic quality was diminished espe-
cially in the abdominal vessel regions due to low SNR. It
is thus possible that renal artery stenoses were missed. The
association with renal artery stenoses and CAD has been
well recognized [30], it is thus likely that an improvement
of image quality with the detection of more renal artery
stenoses will further strengthen our findings of the close
association between extra-cardiac and coronary athero-
sclerosis. We believe that limitations in image quality can
be overcome by new technical developments aiming to
improve spatial resolution and signal-to-noise ratio such
as imaging at 3 T [25,31], the use of multi-channel
receiver and body-surface coils with parallel imaging tech-
niques [16,19,25], subsystolic venous compression [21-
24] and possibly the application of blood pool contrast
agents [32].
Conclusion
Our findings support the concept of a WB-MRA derived
atherosclerosis score index as marker for systemic athero-
sclerotic burden. The close relationship between the
atherosclerosis score index and the presence of significant
coronary artery disease and its correlation with traditional
established risk scores suggest that the score may be of
prognostic significance and underlines the importance to
screen for coronary disease in patients with extra-cardiac
stenoses. We further postulate that the ASI will be a valu-
able tool for longitudinal studies of atherosclerosis'
pathophysiology and progression.
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